Company lists
The New York City edition · 2026

Life sciencescompanies in New York City

Life sciences tech, oncology, genomics, neurology, startups and more: the companies building life sciences in New York City, New York, with their founders, funding, team size and business models.

605 company profiles219 with recorded fundingNovember 2026 edition
New York City · Photo: Wikimedia Commons (CC BY-SA 4.0)

Recent life sciences business events in New York City

Funding, M&A, contract wins and launches involving 857 life sciences companies in New York City, last 24 months: 78 M&A deals · 67 funding rounds · 13 Contracts · 4 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.

ContractSupply

Beijing mabworks biotech · client: Everest medicines

Everest Medicines announced that it has entered into a commercialization license agreement with Beijing Mabworks Biotech Co., Ltd. under which the Company has obtained exclusive rights…

Pharmaceutical
FundingSeries A

Waypoint bio

Waypoint Bio, an innovative biotechnology firm leveraging artificial intelligence to pioneer advanced CAR T-cell therapies for challenging solid tumors, has successfully closed a $20…

Investors Amplify partners, General catalyst, Time bioventures, Mitsui Global Investments
Biotechnology
M&AAcquisition · Announced

Dragos acquires Phosphorus

Dragos has acquired Phosphorus, broadening its reach across connected devices in operational environments.

Cybersecurity / device discovery and remediation software
M&AAcquisition · Announced

Dragos acquires Phosphorus

Dragos enhances its xOT cybersecurity platform with the acquisition of Phosphorus, bolstering defense for critical infrastructure's connected devices.

XOT Cybersecurity
M&AAcquisition · Announced

UCB S.A. acquires Candid

Candid is choosing the M&A route instead, opting to accept a $2 billion buyout offer that gives UCB the biotech’s pipeline of T cell engagers for immune disorders.

Biotech
M&AAcquisition · Announced

Merchant acquires Sowell

Sowell Launches 'Family Office Lite,' Advisor Partnership Program Merchant has agrees to provide funding for future M&As to the RIA led by Bill Sowell.

Registered Investment Advisor (RIA)
M&AAcquisition · Announced

Unnamed entity acquires Rocket pharmaceuticals

Rocket Pharmaceuticals announced this week the sale of its rare pediatric disease priority review voucher (PRV) for $180 million.

Biotechnology
FundingUnderwritten registered direct offering

Lucid diagnostics

Lucid Diagnostics on Thursday announced that it had priced an underwritten registered direct offering of 18,000,000 common shares at a purchase price of $1.00 per share for total…

Investors Fundamental institutional investor
Diagnostics
M&AAcquisition · Announced

Everest medicines acquires Hasten Biopharmaceuticals (Asia)

Everest Medicines’ wholly owned subsidiary EverSea Medicines (Singapore) has signed a share purchase agreement to conditionally acquire Hasten Biopharmaceuticals, a subsidiary of Hasten…

Pharmaceuticals
FundingLoan facility

Hyperfine

Horizon Technology Finance Corporation announced it has provided a $40 million loan facility to Hyperfine, Inc., with an initial $15 million funded at closing and up to $25 million…

Health technology
M&AAcquisition · Completed

Protagenic therapeutics acquires Phytanix Bio

Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company developing first-in-class treatments for stress-related neuropsychiatric disorders, today announced…

Biopharmaceutical
Funding

Axsome therapeutics

Deals included a $2.7 billion financing for cloud services platform Dropbox and $570 million for Axsome Therapeutics.

Investors Na
Funding

Esper bionics

One of the standout healthtech deals was Esper Bionics, which secured $5 million in a round led by YZR Capital.

Investors YZR Capital
Healthtech
M&AAcquisition · Announced

Pfizer and Novo Nordisk acquires Metsera

Pfizer’s fight with Novo Nordisk to buy obesity drug start-up Metsera

Biotech
M&AAcquisition

Epicured acquires Chiyo

Epicured, a food-is-medicine meal delivery company originally focused on digestive health, has acquired Chiyo, a women’s nutrition company offering stage-specific meal programs spanning…

FundingSeries B

Iliad biotechnologies

ILiAD Biotechnologies , a biotech based in FL, USA raised a $115 M Series B funding round.

Biotech
FundingPrivate Placement

Immunic

Immunic, Inc. (Nasdaq: IMUX), a late‑stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today announced the…

Investors BVF Partners L.P., Aberdeen Investments, Avidity Partners, Coastlands Capital
Biotechnology
Contract

Evolutionary biologics · client: Revive

Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), announces that the 'Exclusive Distribution Agreement' dated July 1, 2025, between Evolutionary Biologics (a wholly owned…

Regenerative Medicine
LaunchTaia

Thorne

In fact, ... One example is healthtech company Thorne, which recently unveiled Taia, its AI-powered wellness advisor.

AI-powered wellness advisor
FundingPrivate Placement

Lb pharmaceuticals

LB Pharmaceuticals Inc announced that it has entered into a securities purchase agreement to sell 3,306,571 shares of its common stock and pre-funded warrants to purchase up to 1,417,107…

Investors Balyasny Asset Management L.P., Caligan partners, Commodore Capital, Deep track capital
Biopharmaceutical
Funding

Daxor Corporation

Daxor Corporation (NasdaqCM: DXR) ("Daxor" or the "Company") announced today that it has entered into a definitive agreement with fundamental investors for the purchase and sale of an…

Investors Fundamental investors
Healthcare
ContractGovernment

Lucid diagnostics · client: U.S. Dept of Veterans Affairs

Lucid Diagnostics awarded U.S. Dept of Veterans Affairs contract for EsoGuard

M&AAcquisition · Completed

Sun pharmaceutical industries acquires Checkpoint therapeutics

Last year (2025), Sun Pharma acquired Checkpoint Therapeutics for a total deal value of $416 million, helping it access a range of advanced immunotherapies used for targeted treatment…

Biotechnology
M&AAcquisition · Completed

Midea group acquires Carestream Health

Carestream Health has completed a comprehensive restructuring and has formally split its business into two geographically oriented companies, and has sold its international medical…

FundingPrivate placement

Intelligent bio solutions

Intelligent Bio Solutions (INBS) stock dove on Friday after the biotechnology company announced a private placement with institutional investors. This $10 million private placement…

Biotechnology
M&AAcquisition · Announced

Dassault Systèmes acquires Medidata Solutions

In an anticipated move, Dassault Systèmes, a French enterprise IT firm (its better-known aviation business is a separate company) will acquire Medidata Solutions, at a 17% premium over…

Life Sciences Software
M&AAcquisition · Announced

Veeva acquires Crossix

On the surface, the acquisition by Veeva seems to be a lot of money for what it’s getting—the purchase price works out to about $2.4 million per Crossix employee (there’s also $120…

FundingSecurities purchase agreement

Tonix pharmaceuticals

Tonix Pharmaceuticals (TNXP) entered into a securities purchase agreement with Point72 for the purchase and sale of 615,025 shares of its common stock at an offering price of $16.26 per…

Investors Point72
Pharmaceuticals
FundingGrowth capital

Nanit

Nanit has raised $50 million in a growth capital round led by Springcoast Partners, with participation from Upfront Ventures and JVP.

Investors Springcoast Partners, Upfront ventures, JVP
AI
FundingPublic offering

Immunovant

Sidley represented Immunovant, Inc., a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, in its US$550 million underwritten…

Clinical-stage immunology

Life sciences companies in New York City, by funding and team

Few life sciences companies in New York City, New York publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 605 active companies.

Showing 25 of 50

Provider of a digital platform for weight loss management and behavior change

Fitness & wellness tech
US$623.85mSeries F · May 2021
1,202-41% 12 mo to Dec 2023LinkedIn · Oct 2026
Subscription
18 yr2008
0none in 3 months

Provider of AI-powered drug discovery platform for various diseases

Life sciences tech
US$608.25mSeries D · May 2024
195LinkedIn · Oct 2026
Subscription
10 yr2016
0none in 3 months · last posted Mar 2026

AI and cloud-based platforms provide data-driven insights to healthcare providers

Healthcare it
US$514.00mSeries E · Nov 2022
756+33% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
12 yr2014
0none in 3 months · last posted Jul 2026

Discovering novel therapeutics for neurological and metabolic diseases

Life sciences platforms and tools
US$479.00mSeries D · Feb 2022
53+31% 12 mo to Dec 2021LinkedIn · Oct 2026
Subscription
12 yr2014
0none in 3 months

Provider of medical affair services for biopharma and medical device industry

Life sciences tech
US$320.86mSeries C · Jun 2022
583LinkedIn · Oct 2026
Subscription
9 yr2017
0none in 3 months

Developer of drugs for the treatment of cancer

Immunology
US$313.00mSeries C · Jun 2020
155LinkedIn · Oct 2026
Physical commerce
9 yr2017
0none in 3 months

Developer of closed-system transfer devices for handling drugs

Hospital equipment
US$300.00mSeries D · Oct 2022
61-3% 12 mo to Dec 2022recorded Dec 2022
Commission on transaction / E-commerce - product
17 yr2009
0none in 3 months

Developer of therapeutics for cancer treatment

Oncology
US$275.35mSeries A · Oct 2019
248+132% 12 mo to Dec 2021LinkedIn · Oct 2026
Physical commerce
8 yr2018
0none in 3 months · last posted Oct 2025

Provider of clinical research healthcare services

Life sciences tech
US$203.00mSeries A · Jan 2023
199LinkedIn · Jul 2026
Subscription
23 yr2003
—No postings tracked

Developer of gene therapy for the treatment of CLN2 Batten and Alzheimer's diseases

Neurology
US$185.00mSeries B · Aug 2023
103+2% vs previous recordLinkedIn · Oct 2026
Physical commerce / Subscription
8 yr2018
0none in 3 months · last posted Nov 2025

Developer of therapeutics for the treatment of rare neurological disorders

Genomics
US$183.50mSeries B · Dec 2020
141-12% vs previous recordLinkedIn · Oct 2026
Fee-for-service
25 yr2001
0none in 3 months · last posted Jan 2025

Developed of brain-computer interface tool for medical treatment and drug development

Brain computer interface
US$182.65mSeries C · Nov 2025
147-31% vs previous recordLinkedIn · Oct 2026
Fee-for-service
5 yr2021
0none in 3 months · last posted Jul 2026

Provider of an automated platform for patients and clinics to manage frozen eggs and embryos

Women health
US$176.91mSeries D · Jun 2024
63+55% 12 mo to Dec 2021LinkedIn · Jul 2026
Subscription
12 yr2014
0none in 3 months

Developer of immunity-inducing vaccine for the prevention and treatment of pertussis

Infectious diseases
US$166.17mSeries B · Feb 2026
29+100% 12 mo to Dec 2021LinkedIn · Jul 2026
E-commerce - product / Physical commerce
14 yr2012
0none in 3 months

Developer of drugs for neuropsychiatric conditions

Neurology
US$151.55mSeries B · Mar 2026
35-91% vs previous recordLinkedIn · Jul 2026
Physical commerce
7 yr2019
0none in 3 months · last posted Jan 2026

Developer of dental aligners

Dental disorders
US$147.78mSeries B · Dec 2020
298+84% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
9 yr2017
0none in 3 months

Developer of medications to treat ophthalmic diseases

Ophthalmology
US$142.20mSeries B · Mar 2012
11recorded
E-commerce - product / Physical commerce
20 yr2006
0none in 3 months

Provider of an AI models for protein design

Life sciences tech
US$142.00mSeed · Jun 2024
18LinkedIn · Jul 2026
Subscription
3 yr2023
0none in 3 months

Developer of small molecule based therapeutics for schizophrenia

Neurology
US$130.09mSeries C · Aug 2023
1LinkedIn · Oct 2026
Fee-for-service
11 yr2015
0none in 3 months

Developer of therapeutics for the treatment of solid and liquid cancers

Oncology
US$128.15mSeries B · May 2021
25-13% vs previous recordLinkedIn · Oct 2026
Subscription
11 yr2015
0none in 3 months

Developer of hemostatic products for wound care

Wound care
US$118.35mSeries B · Apr 2026
92+38% 12 mo to Dec 2022LinkedIn · Jul 2026
E-commerce - product / Physical commerce
16 yr2010
0none in 3 months · last posted Jan 2026

Developer of therapeutics for cancer treatment

Genomics
US$117.27mSeries B · Sep 2025
41+50% 12 mo to Dec 2021LinkedIn · Jul 2026
Fee-for-service
7 yr2019
0none in 3 months · last posted May 2026

Provider of smart baby monitoring systems with sleep and breathing analysis

Sleep medicine
US$116.60mSeries D · Dec 2025
208+1% vs previous recordLinkedIn · Oct 2026
Subscription
12 yr2014
0none in 3 months · last posted Oct 2025

Proton Beam Therapy. Treatment for different types of Cancerous and non-cancerous tumors through Proton Therapy.

Oncology
US$115.61mSeries F · Feb 2011
78+7% 12 mo to Dec 2014LinkedIn · Oct 2026
Fee-for-service
21 yr2005
0none in 3 months

Developer of therapeutics to treat neurological diseases

Neurology
US$114.00mSeries A · Aug 2025
35LinkedIn · Jul 2026
Fee-for-service
5 yr2021
0none in 3 months
50 of 605 companies shown here · the full list is on Radar
Fliar Radar

Explore all 605 life sciences companies in New York City on Radar

This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.

Open life sciences in New York City on Radar
  • Every company, not just 50All 605 life sciences companies in New York City, filterable by stage, funding, team size, revenue model and age.
  • Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
  • Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
  • Save and exportBuild lists, compare companies side by side and export them from your Radar account.

Explore life sciences companies in New York City by what you are looking for

Find top life sciences companies in New York City across drug discovery, oncology and genomics. Explore life sciences startups in New York City, research tools and clinical technology providers.

7 ways to explore life sciences in New York City

Life sciences technology companiesOncology and cancer treatment companiesGenomics and genetic testing companiesNeurology and rare disease companiesLife sciences startups in New York CityLife sciences companies hiring in New York City

Life sciences technology companies

Technology platforms and tools supporting life sciences work.

  1. Formation Bio

    Provider of AI-powered drug discovery platform for various diseases

    Life sciences tech
    See in list
  2. Paradigm

    Provider of clinical research healthcare services

    Life sciences tech
    See in list
  3. EvolutionaryScale

    Provider of an AI models for protein design

    Life sciences tech
    See in list
  4. Proxima

    Developer of a platform for programmable protein interaction-based drug discovery

    Life sciences tech
    See in list
  5. Castor

    Electronic Data Capture (EDC), eCRF, ePRO application for online data collection for medical research

    Life sciences tech
    See in list

Oncology and cancer treatment companies

Companies developing cancer therapies, diagnostics and treatment tools.

  1. Everest Medicines

    Developer of drugs for the treatment of cancer

    Immunology
    See in list
  2. Nuvation Bio

    Developer of therapeutics for cancer treatment

    Oncology
    See in list
  3. Hibercell

    Developer of therapeutics for the treatment of solid and liquid cancers

    Oncology
    See in list
  4. ProCure

    Proton Beam Therapy. Treatment for different types of Cancerous and non-cancerous tumors through Proton Therapy.

    Oncology
    See in list
  5. Flame Biosciences

    Manufacturer of drugs for treating inflammation

    Immunology
    See in list

Genomics and genetic testing companies

Businesses working on sequencing, genomics and genetic analysis.

  1. Kallyope

    Discovering novel therapeutics for neurological and metabolic diseases

    Life sciences platforms and tools
    See in list
  2. Neurogene

    Developer of therapeutics for the treatment of rare neurological disorders

    Genomics
    See in list
  3. Volastra

    Developer of therapeutics for cancer treatment

    Genomics
    See in list
  4. Gotham Therapeutics

    Developer of therapeutics for cancer

    Genomics
    See in list
  5. Celmatix

    Pioneering ovarian health therapeutics for women's unique biological needs

    Women health

Neurology and rare disease companies

Life sciences companies focused on neurological and rare diseases.

  1. LEXEO Therapeutics

    Developer of gene therapy for the treatment of CLN2 Batten and Alzheimer's diseases

    Neurology
    See in list
  2. Neurogene

    Developer of therapeutics for the treatment of rare neurological disorders

    Genomics
    See in list
  3. Gilgamesh

    Developer of drugs for neuropsychiatric conditions

    Neurology
    See in list
  4. LB Pharmaceuticals

    Developer of small molecule based therapeutics for schizophrenia

    Neurology
    See in list
  5. Leal Therapeutics

    Developer of therapeutics to treat neurological diseases

    Neurology
    See in list

Life sciences startups in New York City

Recently founded life sciences companies in New York City.

  1. Precision Neuroscience

    Developed of brain-computer interface tool for medical treatment and drug development

    Brain computer interface
    See in list
  2. EvolutionaryScale

    Provider of an AI models for protein design

    Life sciences tech
    See in list
  3. Leal Therapeutics

    Developer of therapeutics to treat neurological diseases

    Neurology
    See in list
  4. Nilo Therapeutics

    Developer of therapies targeting neural circuits for immune and inflammatory diseases

    Immunology
    See in list
  5. Elion Therapeutics

    Developer of therapeutics for invasive fungal infections

    Infectious diseases
    See in list
87 companies in New York City

Life sciences companies hiring in New York City

Life sciences employers with hiring activity in New York City.

  1. Formation Bio

    Provider of AI-powered drug discovery platform for various diseases

    Life sciences tech
    See in list
  2. Komodo Health

    AI and cloud-based platforms provide data-driven insights to healthcare providers

    Healthcare it
    See in list
  3. Nuvation Bio

    Developer of therapeutics for cancer treatment

    Oncology
    See in list
  4. LEXEO Therapeutics

    Developer of gene therapy for the treatment of CLN2 Batten and Alzheimer's diseases

    Neurology
    See in list
  5. Neurogene

    Developer of therapeutics for the treatment of rare neurological disorders

    Genomics
    See in list
27 companies in New York City

Public life sciences companies in New York City

Publicly listed life sciences companies in New York City.

  1. Everest Medicines

    Developer of drugs for the treatment of cancer

    Immunology
    See in list
  2. Nuvation Bio

    Developer of therapeutics for cancer treatment

    Oncology
    See in list
  3. LEXEO Therapeutics

    Developer of gene therapy for the treatment of CLN2 Batten and Alzheimer's diseases

    Neurology
    See in list
  4. Neurogene

    Developer of therapeutics for the treatment of rare neurological disorders

    Genomics
    See in list
  5. LB Pharmaceuticals

    Developer of small molecule based therapeutics for schizophrenia

    Neurology
    See in list
63 companies in New York City
Mobile reach

Top 9 life sciences apps from New York City

The most-installed Android apps published by life sciences companies headquartered in New York City — 23.0M installs between them. 9 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.

1 of 9
1

Noom: Weight Loss & GLP-1 Care

by Noom

Installs22.8M
Rating4.09314K ratings
Installs, year on year+2%
Last updatedJun 2026
Noom: Weight Loss & GLP-1 Care screenshot 1Noom: Weight Loss & GLP-1 Care screenshot 2Noom: Weight Loss & GLP-1 Care screenshot 3Noom: Weight Loss & GLP-1 Care screenshot 4Noom: Weight Loss & GLP-1 Care screenshot 5Noom: Weight Loss & GLP-1 Care screenshot 6
2

Hungryroot: Healthy Groceries

by Hungryroot

Installs176K
Rating4.73822 ratings
Last updatedJun 2026
Hungryroot: Healthy Groceries screenshot 1Hungryroot: Healthy Groceries screenshot 2Hungryroot: Healthy Groceries screenshot 3Hungryroot: Healthy Groceries screenshot 4Hungryroot: Healthy Groceries screenshot 5
3

Newtopia

by Newtopia

Installs19K
Rating2.84267 ratings
Last updatedApr 2026
Newtopia screenshot 1Newtopia screenshot 2Newtopia screenshot 3Newtopia screenshot 4Newtopia screenshot 5
4

NOVOS Life

by NOVOS

Installs13K
Rating3.4357 ratings
Last updatedJan 2026
NOVOS Life screenshot 1NOVOS Life screenshot 2NOVOS Life screenshot 3NOVOS Life screenshot 4
5

CalmiGo

by CalmiGo

Installs6K
Rating4.32155 ratings
Last updatedJun 2026
CalmiGo screenshot 1CalmiGo screenshot 2CalmiGo screenshot 3CalmiGo screenshot 4CalmiGo screenshot 5
6

Drug Hunter

by Drug Hunter

Installs439
Rating—
Last updatedApr 2026
Drug Hunter screenshot 1Drug Hunter screenshot 2Drug Hunter screenshot 3Drug Hunter screenshot 4Drug Hunter screenshot 5Drug Hunter screenshot 6
7

MilkMate

by MilkMate

Installs104
Rating—
Last updatedMay 2026
MilkMate screenshot 1MilkMate screenshot 2MilkMate screenshot 3MilkMate screenshot 4MilkMate screenshot 5MilkMate screenshot 6
8

VOOM Medical Devices

by Voom Medical Devices

Installs34
Rating—
Last updatedOct 2025
VOOM Medical Devices screenshot 1VOOM Medical Devices screenshot 2
9

AminoChain

by AminoChain

Installs5
Rating—
Last updatedMay 2026
AminoChain screenshot 1AminoChain screenshot 2
RadarBrowse every life sciences company in New York City on RadarOpen the full list and use the App Downloads and App Growth filters to keep only companies with a mobile app. This rail shows only the ten most-installed.Browse on Radar
For investors and data teams

Put this intelligence into your own tools

The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.

Capital & corporate activity

Life sciences funding and M&A across the United States

22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how New York City compares. Debt, IPO and grant rounds are excluded.

equity rounds, last 12 months360

US$13.54bn

equity rounds, last 24 months1232

US$37.38bn

raised over five yearsUS$157.58bn

5,603 rounds in the United States

M&A deals, New York City78

last 24 months

Capital by year

Equity funding into life sciences in the United States

amount rounds
$26bn20181450
$23bn20191352
$32bn20201398
$45bn20211383
$30bn20221075
$22bn20231064
$25bn2024940
$23bn2025850
$12bn2026291

Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.

The funding ladder · five years

Rounds and typical cheque by stage

AngelUS$70.78m18 rounds · median US$1.40m
SeedUS$5.87bn1,808 rounds · median US$1.11m
Series AUS$38.68bn1,753 rounds · median US$8.80m
Series BUS$46.06bn1,089 rounds · median US$23.00m
Series CUS$30.98bn517 rounds · median US$42.00m
Series D+US$35.59bn392 rounds · median US$50.00m
Private equityUS$66.54m22 rounds · median US$14.25m
Where the money went · five years

Most-funded sub-sectors

OncologyUS$24.87bn658 rounds · 368 companies
Life sciences techUS$16.70bn556 rounds · 344 companies
GenomicsUS$15.90bn409 rounds · 249 companies
NeurologyUS$13.39bn445 rounds · 248 companies
ImmunologyUS$12.90bn189 rounds · 111 companies
Life sciences platforms and toolsUS$7.97bn387 rounds · 238 companies
Cardiac and vascular disordersUS$7.63bn313 rounds · 172 companies
Corporate activity · last 24 months

M&A in New York City

68Acquisition
8Merger
2Announced

Most active acquirers

  1. Merck KGaA5
  2. Sun pharmaceutical industries4
  3. Abbvie4
  4. Merck4
  5. Pfizer3

Most acquired or merged

  1. Springworks therapeutics8
  2. Metsera6
  3. Checkpoint therapeutics5
  4. Tourmaline bio4
  5. Intra-cellular therapies4

Each deal appears in the events strip at the top of the page.

Industry landscape report

Life Sciences Industry Landscape of New York City

The financials above are one chapter. The full life sciences landscape of New York City maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.

  • Market map of every sub-sector
  • Funding & company formation by year
  • Revenue, profit & financial strength
  • Digital footprint: traffic, apps, releases
  • Hiring, skills & pay
  • Founders & leaders
  • News & sentiment
  • Where demand runs ahead of supply
Read the life sciences landscape of New York City

Life sciences funding in New York City

219 life sciences companies in New York City have recorded equity funding, US$9.92bn in total. Totals and round dates describe the historical record; they are not current valuations.

Founders and momentum in New York City

Meet the people behind life sciences companies in New York City. 456 of 605 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.

Explore New York City life sciences companies by sub-sector

The most common specialisations among life sciences companies in New York City. Open a company to see what it sells, who runs it and how far it has come.

Keep exploring life sciences in the United States and nearby markets.

Explore more lists: nearby cities and other sectors in New York City

260 more company lists you can search, plus the Radar directory pages for each place.

Life sciences in nearby cities

Life sciences in other US cities

Other sectors in New York City

Browse the Radar directory

Coming soon